Perez, Elviliza T.

HRN: 06-68-71  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/02/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/02/2024
03/08/2024
IV
600
Every 8 Hours
Abscess
Waiting Final Action 
03/02/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/02/2024
03/09/2024
IV
1.5 Grams
Q6H
Wound Abscess, Left Axilla
Waiting Final Action 
03/03/2024
CEFTAZIDIME 1GM (VIAL)
03/03/2024
03/09/2024
IV
2g
Q8h
T/c Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: